![Ibrahim Dagher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ibrahim Dagher
No open positions remaining
Net worth: 79 515 $ as of 2026-06-29
Profile
Ibrahim B. Dagher worked as Senior Medical Director at Labcorp Drug Development, Inc. from 2018 to 2019.
From 2019 to 2021, served as Chief Medical Officer-WCG MedAvante-ProPhase at Cadent Therapeutics, Inc. Held the position of Chief Medical Officer at MedAvante-ProPhase, Inc. Worked as Chief Medical Officer at Enveric Biosciences, Inc. from 2021 to 2023.
From 2024 to 2026, held the role of Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. Completed undergraduate education at Université de Bordeaux and Faculté De Médecine Necker Enfants Malades Université.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-25 | 79,515 ( 0.72% ) | 79 515 $ | 2026-06-29 |
Former positions of Ibrahim Dagher
| Companies | Position | End |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2026-07-25 |
| ENVERIC BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Corporate Officer/Principal | 2021-11-30 |
| COVANCE INC. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
MedAvante-ProPhase, Inc.
 MedAvante-ProPhase, Inc. Information Technology ServicesTechnology Services Provides echnology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders | Chief Tech/Sci/R&D Officer | - |
Training of Ibrahim Dagher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Université de Bordeaux
 Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
MedAvante-ProPhase, Inc.
MedAvante-ProPhase, Inc. Information Technology ServicesTechnology Services Provides echnology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders | Technology Services |
Faculté De Médecine Necker Enfants Malades Université
 Faculté De Médecine Necker Enfants Malades Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
- Stock Market
- Insiders
- Ibrahim Dagher
